Turn Therapeutics Inc.
TTRX
$13.75
$1.098.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -230.13% | -124.70% | -80.63% | -103.81% | -58.55% |
| Total Depreciation and Amortization | 15.18% | 13.43% | 11.16% | 17.51% | 24.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.91% | -413.35% | -594.61% | 66.51% | 10,593.75% |
| Change in Net Operating Assets | 610.23% | 612.22% | 124,652.63% | 497.80% | -21.07% |
| Cash from Operations | -169.24% | -181.99% | -88.26% | -40.15% | -24.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.51% | -119.10% | -53.77% | -20.82% | -5.19% |
| Cash from Investing | -40.61% | -80.94% | -69.75% | -35.67% | -25.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.28% | 250.06% | 500.38% | 576.49% | 1,201.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 189.49% | 586.36% | 500.38% | 576.49% | 1,201.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 207.97% | 1,687.44% | 1,463.00% | 399.66% | 317.81% |